Study of Disitamab Vedotin Combined With Gemcitabine in Neoadjuvant Treatment of Urothelial Carcinoma
NCT05723991
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
36
Enrollment
OTHER
Sponsor class
Conditions
Radical Cystectomy
Urothelial Carcinoma
Interventions
DRUG:
Disitamab Vedotin and Gemcitabine
Sponsor
Chunguang yang (101937)